Eli Lilly Aktie

693,30 EUR -3,80 EUR -0,55 %

17:08:23

XETRA

809,36 USD +9,79 USD +1,22 %

17:23:23

BTT

Eli Lilly jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.659,58 Mrd. EUR

KGV65,91Div. Rendite0,67%

WKN858560

ISINUS5324571083

SymbolLLY

Eli Lilly Aktien News

Sortieren:Datum Meistgelesen

21.10.25ZacksEli Lilly (LLY) Stock Moves -1.16%: What You Should Know

21.10.25MotleyFoolDid Eli Lilly Just Say "Checkmate" to Novo Nordisk?

20.10.25BenzingaHere's How Much $100 Invested In Eli Lilly 20 Years Ago Would Be Worth Today

WerbungEli Lilly-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

20.10.25ZacksEli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

20.10.25MotleyFoolJ.L. Bainbridge Buys $45 Million in Eli Lilly Stock Despite Price-Pressure Fears

17.10.25BenzingaEli Lilly Shares Are Trading Lower Friday: What's Going On?

17.10.25EN, Eli LillyLilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

17.10.25PR NewswireLilly's Verzenio® (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment

17.10.25ZacksThe Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and Viking Therapeutics

17.10.25MotleyFoolEli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?

16.10.25BenzingaEli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs'

16.10.25MotleyFoolChesapeake Sells 9,900 Eli Lilly (LLY) Shares Worth $7.7 Million

16.10.25EN, Eli LillyLilly confirms date and conference call for third-quarter 2025 financial results announcement

16.10.25PR NewswireLilly confirms date and conference call for third-quarter 2025 financial results announcement

15.10.25ZacksEli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know

15.10.25EN, Eli LillyLilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

15.10.25PR NewswireLilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

15.10.25MotleyFool1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today

14.10.25MotleyFoolIndependence Bank of Kentucky Buys Another $3.1 Million Eli Lilly (NYSE: LLY) Shares

14.10.25ZacksThe Zacks Analyst Blog Highlights Apple, Eli Lilly and Visa

13.10.25ZacksTop Stock Reports for Apple, Eli Lilly & Visa

13.10.25BenzingaHealthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs

13.10.25EN, Eli LillyLilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting

13.10.25PR NewswireLilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting

13.10.25EN, Eli LillyWHO Foundation and Lilly Collaborate to Support Global Dementia Action Plan

11.10.25MotleyFoolShould Investors Buy Eli Lilly Stock?

09.10.25ZacksEli Lilly (LLY) Gains As Market Dips: What You Should Know

09.10.25ZacksAbbVie vs. Eli Lilly: Which Large Drugmaker Has the Edge in 2025?

09.10.25MotleyFoolWatch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market

08.10.25BenzingaEli Lilly To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

07.10.25ZacksInvestors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know

07.10.25EN, Eli LillyLilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis

07.10.25PR NewswireLilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis

07.10.25Business TimesEli Lilly to invest US$1 billion in India contract manufacturing

07.10.25Benzinga$1000 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today

06.10.25BenzingaEli Lilly Eyes India For Manufacturing, Plans To Spend $1 Billion

06.10.25ZacksEli Lilly Stock Rises 16% in a Week: Here's What You Should Know

06.10.25MotleyFoolEli Lilly: Beyond Weight Loss

06.10.25ZacksZacks Value Trader Highlights: Pfizer, Merck, AbbVie, Eli Lilly and Novo Nordisk

03.10.25ZacksEli Lilly (LLY) Laps the Stock Market: Here's Why

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.